GlycanAge: Funding, Investors & Team (Oct 2026)
GlycanAge was founded to accelerate the shift from reactive to proactive health, for which we need biomarkers. Changing more than a decade before CVD events, hypertension, insulin resistance, etc. glycans are the dark horse in the race to longevity and key to unlocking this multi-trillion dollar industry. To enable that, GlycanAge has packaged a best-in-class solution into a simple take-home test.
GlycanAge has raised $13.5M across 3 funding rounds on record, the most recent an undisclosed round of $8.7M announced in Dec 2025.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GlycanAge Company Profile and Key Stats
Latest funding round on record: Dec 2025.
GlycanAge Funding Rounds
GlycanAge raised $4.2M in a Seed announced in Feb 2024.
1.3 years later, a Seed of $570k was announced in May 2025.
7 months later, an undisclosed round of $8.7M was announced in Dec 2025.
GlycanAge Founders and Leadership Team
Contact details for the GlycanAge team: 1 of 1 has an email address on file.
Start 14-day free trial →GlycanAge Funding Compared to Other Biotechnology Startups
GlycanAge's latest round of $8.7M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GlycanAge in Biotechnology and Newcastle Upon Tyne
Companies Similar to GlycanAge
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
GlycanAge Funding FAQs
What does GlycanAge do?
GlycanAge was founded to accelerate the shift from reactive to proactive health, for which we need biomarkers. Changing more than a decade before CVD events, hypertension, insulin resistance, etc. glycans are the dark horse in the race to longevity and key to unlocking this multi-trillion dollar industry. To enable that, GlycanAge has packaged a best-in-class solution into a simple take-home test.
How much funding has GlycanAge raised?
GlycanAge has raised $13.5M across 3 rounds on record. The most recent is an undisclosed round of $8.7M announced in Dec 2025.
When did GlycanAge last raise funding?
GlycanAge's most recent funding round on record is an undisclosed round of $8.7M, announced in Dec 2025.
Who founded GlycanAge?
FundedIQ lists Nikolina Lauc (Founder) at GlycanAge.
Where is GlycanAge headquartered?
GlycanAge is based in Newcastle Upon Tyne, United Kingdom.
How many employees does GlycanAge have?
GlycanAge is in the 11-50 employee band.
How does GlycanAge's funding compare to other Biotechnology startups?
GlycanAge's latest round of $8.7M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's GlycanAge Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GlycanAge is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.